Exiqon announced that it has named Mark Willig as its chief commercial officer.
He will be responsible for managing the company’s sales and marketing efforts for all products and services.
Willig most recently served as vice president of global sales at Thermo Fisher Scientific.
Mirna Therapeutics has appointed Paul Lammers as its president, CEO, and board member.
Lammers was most recently president of Repros Therapeutics. Before that, he was CEO of EMD Serono. He holds an MD and MSc from Catholic University in the Netherlands.